Leading Companies

Companies covered:

SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc

Global Artificial Vital Organs And Medical Bionics Market- Key Players

Major players operating in the global Artificial Vital Organs And Medical Bionics market include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.

By Type, the market is segmented into Artificial vital organs (artificial heart, artificial kidney, artificial liver, artificial pancreas, artificial lungs), and Medical bionics (cochlear implants, vision bionics, exoskeletons, bionic limbs, brain bionics, cardiac bionics). Out of which, the artificial vital organs (artificial heart, artificial kidney, artificial liver, artificial pancreas, artificial lungs) is expected to hold a dominant position in the global artificial vital organs and medical bionics market during the forecast period and this is attributed to increasing organ transplant surgeries.

By End User, the market is segmented into hospitals, clinics, and ambulatory surgical centers.